Narae Nanotech Balance Sheet Health
Financial Health criteria checks 1/6
Narae Nanotech has a total shareholder equity of ₩89.8B and total debt of ₩64.1B, which brings its debt-to-equity ratio to 71.4%. Its total assets and total liabilities are ₩173.0B and ₩83.2B respectively.
Key information
71.4%
Debt to equity ratio
₩64.10b
Debt
Interest coverage ratio | n/a |
Cash | ₩7.23b |
Equity | ₩89.79b |
Total liabilities | ₩83.16b |
Total assets | ₩172.96b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: A137080's short term assets (₩65.8B) do not cover its short term liabilities (₩68.8B).
Long Term Liabilities: A137080's short term assets (₩65.8B) exceed its long term liabilities (₩14.3B).
Debt to Equity History and Analysis
Debt Level: A137080's net debt to equity ratio (63.3%) is considered high.
Reducing Debt: Insufficient data to determine if A137080's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: A137080's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if A137080's interest payments on its debt are well covered by EBIT.